Rare diseases, orphan drugs, and orphaned patients

被引：11
作者：
Scheindlin, Stanley
机构：
来源：
MOLECULAR INTERVENTIONS | 2006年 / 6卷 / 04期
关键词：
D O I：
10.1124/mi.6.4.2
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：186 / 191
页数：6
相关论文
共 16 条
[1]  
BRIDGES A, 2006, INQUIRER 0429
[2]  
CARREL L, BREATHLESS ENTHUSIAS
[3]   Circumventing resistance to kinase-inhibitor therapy [J].
Druker, Brian J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (24) :2594-2596
[4]   Sildenafil citrate therapy for pulmonary arterial hypertension [J].
Galiè, N ;
Ghofrani, HA ;
Torbicki, A ;
Barst, RJ ;
Rubin, LJ ;
Badesch, D ;
Fleming, T ;
Parpia, T ;
Burgess, G ;
Branzi, A ;
Grimminger, F ;
Kurzyna, M ;
Simonneau, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2148-2157
[5]   Focus on research - Adopting orphan drugs - Two dozen years of treating rare diseases [J].
Haffner, ME .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (05) :445-447
[6]   Rare disease research gets boost [J].
Hampton, T .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (24) :2836-2838
[7]  
HERPER M, 2006, FORBES 0130, P75
[8]   Thiamine shortage - Plight of low-cost, lifesaving orphan drugs [J].
Kumar, PD .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (05) :532-533
[9]  
*NORD INC, NORD FACT SHEET
[10]  
ROSS WR, 1997, MED MARKET MEDIA, V32, P40
12